Rxo (RXO) Receivables (2021 - 2026)

Rxo (RXO) has 6 years of Receivables data on file, last reported at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 5.74% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 5.74% YoY), and the FY2025 full-year result was $1.3 billion, up 0.64% from the prior year.
• Receivables for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
• Across five years, Receivables topped out at $1.3 billion in Q4 2025 and bottomed at $716.0 million in Q1 2024.
• The 5-year median for Receivables is $1.0 billion (2022), against an average of $978.2 million.
• The widest annual swing landed in 2023, when Receivables dropped 22.62%; it then soared 64.99% in 2024.
• A 5-year view of Receivables shows it stood at $900.0 million in 2022, then dropped by 16.22% to $754.0 million in 2023, then jumped by 64.99% to $1.2 billion in 2024, then advanced by 0.64% to $1.3 billion in 2025, then retreated by 2.88% to $1.2 billion in 2026.
• The last three Receivables figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison